Banner Background

We are
INTEGRIS

About Integris Medtech

Integris Medtech Limited is a diversified India-based global medical products and laboratory solutions company, with expertise in developing, manufacturing, commercialising, and selling a broad and integrated portfolio of medical devices and solutions. This portfolio includes cardiovascular devices, clinical diagnostics, and scientific laboratory solutions. We operate manufacturing facilities in India, Germany, and the Netherlands, supporting a portfolio of medical devices and laboratory solutions that are sold in more than 65+ countries.

We have worked with more than 9,500 laboratories and partnered with over 2,000 hospitals and cathlabs worldwide through a portfolio exceeding 22,000 stock keeping units (“SKUs”) comprising both our own manufactured products and those from partner brands in lab solutions and cardiovascular businesses, representing more than 200 brands, as of June 30, 2025.

As of / For three months ended June 30, 2025: Total number of employees: 1,879.

Read More

Our Global Capabilities

0+
Countries
0+
Employees
0+
Hospitals & Cathlabs
0
Manufacturing Units
0+
Brands
0+
Laboratories

Our Global Footprint

With more than 1,800 employees worldwide, we serve a diverse client base across 65 countries. Our manufacturing facilities span across India, Germany, and the Netherlands, supporting a portfolio of medical devices and laboratory solutions.

Map
Mexico
Costa Rica
Dominican Republic
Ecuador
Bolivia
Chile
Argentina
South Africa
Tanzania
Morocco
Algeria
Egypt
Middle East
Nepal
India
Russia
Bangladesh
Myanmar
Thailand
Taiwan
South Korea
Indonesia
Singapore
Malaysia
Philippines
Tunisia
Italy
Spain
Portugal
Switzerland
Netherlands
United Kingdom
Belgium
Austria
Czechia
Estonia
Hungary
Romania
Norway
Finland
Croatia
Slovakia
Ukraine
Belarus
Lithonia
Latvia
Germany
Poland

Our Offerings

Innovation Image

Clinical Diagnostics

Innovation Image

Life Science

Innovation Image

Analytical & Industrial Solutions

Innovation Image

General Laboratory

Innovation Image

Calibration Services

Innovation Image

Custom Services and Support

Innovation Image

Drug Eluting Stents

Innovation Image

Drug Eluting Balloons

Innovation Image

PTCA Balloons

Manufacturing and R&D Facilities

Integris Medtech operates 6 manufacturing facilities across India, Germany, and the Netherlands, our integrated R&D centres anchor ongoing innovation and product development. Together, we deliver world-class MedTech solutions to over 65 countries.

Facility Nature of Holding (Owned/Leased) Products Manufactured Leased by
Unit – I, Dehradun, India Leased Bare Metal Stents Transhealth Private Limited
Unit – II, Dehradun, India Leased PTCA catheter, Crimped Stent Transhealth Private Limited
Unit – III, Dehradun, India Leased Drug Eluting Stents and Vascular accessories Translumina Therapeutics Private Limited
Chennai, India Leased Line Immuno Assay (LIA) strip processor - "Pleaxmat series" CPC Diagnostics Private Limited
Immuno Fluorescence Assay (IFA) Slide processor - "Fluromat 50"
Erythrocyte Sedimentation Rate (ESR) Analyser - "SedratePro Series"
Blood Cell Counter - 3part Hematology fully automated Analyser - "EC60"
Chemiluminescent Immunoassay (CLIA) Analyzer - "I Flash 1200"
Helmond, Netherlands Leased Balloon Catheter Blue Medical Devices BV
Hechingen, Germany Leased Stent Coating facility Translumina GmbH

Awards & Accrediations

No accreditations available.

Year Name of the award
2014 TTPL received a certificate of recognition for “Manufacturing Innovative and New Generation Drug Eluting Stent technology in India with World Class standards of Quality and Clinical Evaluation” from National Interventional Council, an interventional arm of Cardiological Society of India.
2016 TTPL received certificate of recognition for “Highest Growth in Drug Eluting Stent Sales and Being the First Asian company to be rated at par with USFDA approved DES in the latest PCI Guidelines of European Society of Cardiology” from National Interventional Council, an interventional arm of Cardiological Society of India.
TTPL received certificate of recognition for “Highest growth in Drug eluting stent sales & rated at par with USFDA approved DES in the latest PCI Guidelines of European Society of Cardiology” from National Interventional Council, an interventional arm of Cardiology Society of India.
2017 TTPL secured recognition as one of the “Best Asian Healthcare Brands” by Economic Times.
2018 Hausen Bernstein Company Limited received “Distributor Excellence Award” from Euroimmun.
2019 Chemopharm Sdn Bhd received “Rising Star Award” from Mindray.
2020 TTPL received certificate of recognition for “Best Med Device of the year” from Economic Times.
Chemopharm Sdn Bhd received “Asean Business Award” from Asean Business Advisory Council.
Scientific Resources Pte Ltd received “Special Award” for outstanding performance in enabling cross portfolio synergies for nucleic acid chemistry from Bioresearch Technologies.
2021 Chemopharm Sdn Bhd was awarded “Market Breakthrough” by Mindray.
Chemopharm Sdn Bhd was awarded “Gold Service Channel” by Mindray.
Hausen Bernstein Company Limited received “Best Cooperative Partner Award” from Innovita.
Scientific Resources Pte Ltd received “Top Growth Award” in gold tier for outstanding performance in reagents from Bioresearch Technologies.
2022 TTPL received certificate of recognition for “Great place to Work” from Great Place to Work Institute, India.
CPC Diagnostics Private Limited was awarded “Million Dollar Club” for crossing USD 2.00 million1 in sale by the Boditech Med. Inc.
CPC Diagnostics Private Limited received “Contributor Partner Award” from Shenzhen YHLO Biotech Co. Ltd.
Chemopharm Sdn Bhd was awarded “Outstanding Sales” by Integra.
Chemopharm Sdn Bhd received “Best Performance Award” from Mindray.
Chemoscience Phils. Inc. was awarded “Top YOY Growth Performance Channel Partner” by Molecular Devices Inc.
Chemoscience Phils. Inc. was awarded “Sales Quota Achiever” by Molecular Devices Inc.
Chemoscience Phils. Inc. was awarded “Best Imaging Performer” by Molecular Devices Inc.
Scientific Resources Pte Ltd received “Top Growth Award” in platinum tier for outstanding performance in nucleic acid chemistry from Bioresearch Technologies.
Research Instruments Vietnam Company Limited was awarded “Best Performance Distributor Award” by MGI APAC.
2023 TTPL received certificate of recognition for “Great place to Work” from Great Place to Work Institute, India.
TTPL was awarded “Top Revenue Contributor” by Shockwave Medical.
CPC Diagnostics Private Limited was awarded “Million Dollar Club” for crossing USD 3.00 million2 in sale by the Boditech Med. Inc.
CPC Diagnostics Private Limited received “Best Performance Award” from Shenzhen YHLO Biotech Co. Ltd.
CPC Diagnostics Private Limited received “Emerging Channel Partner Award” from Thermo Fisher Scientific Inc.
Chemopharm Sdn Bhd was awarded “4i value Award-Innovation” by Thermo Fisher Scientific Inc.
Chemopharm Sdn Bhd was awarded “Best Performance Award” by Mindray.
Chemopharm Sdn Bhd was awarded “Gold Service Channel” by Mindray.
Research Instruments Vietnam Company Limited. received “Apac Grit Award” from Twist Bioscience.
Research Instruments Vietnam Company Limited secured recognition as “Top performer” for significant sales of MGI brands from MGI APAC.
Research Instruments Vietnam Company Limited was awarded “Excellent Distributor Award” by MGI APAC.
Hausen Bernstein Company Limited received “Strategic Partner Award” from Innovita.
Scientific Resources Pte Ltd secured recognition for “Greatest Growth for Chromatography products” from Teledyne Labs.
2024 TTPL was awarded “Best Newcomer” by Acist Medical Systems.
TTPL received certificate of recognition for “Great place to Work” from Great Place to Work Institute, India.
CPC Diagnostics Private Limited received “Exceptional Sales Award” from Euroimmun.
CPC Diagnostics Private Limited received “Valued Partner Award” from Thermo Fisher Scientific Inc.
Chemopharm Sdn Bhd was awarded “Growth Accelerator” by Avantor.
Chemopharm Sdn Bhd was awarded “Valued Partnership” by Thermo Fisher Scientific Inc.
Chemopharm Sdn Bhd was recognised by Cole – Parmer for highest revenue and high growth in Cole-Parmer branded products in Southeast Asia.
Chemopharm Sdn Bhd was awarded “Gold Service Channel” by Mindray.
Chemopharm Sdn Bhd secured recognition for “Clinical System Division” from Bio Rad.
Research Instruments Pte. Ltd. received “Discovery Channel Partner Award” from Cytiva.
2025 TTPL received certificate of recognition for “Great place to Work” from Great Place to Work Institute, India.
TTPL was awarded “Highest Business Revenue in FY 49” from Ashai Intecc Co. Ltd.
TTPL was awarded “Blackbuck Outstanding Research Institution Award” by Medical Dialogues.

Integris Group Companies